UK says Sanofi, Merck recall some typhoid vaccine batches
LONDON (Reuters) - Sanofi Pasteur MSD, the vaccine joint venture of Sanofi and Merck & Co, has recalled some batches of its typhoid vaccine because of concerns about effectiveness, Britain's drug regulator said on Monday.
The decision to recall 16 batches of Typhim Vi follows filling problems in the manufacturing process, according to the Medicines and Healthcare Products Regulatory Agency.
"There are no concerns over the safety of this vaccine but the recall has taken place because the vaccine may not be as effective as it should be," agency official Ian Holloway said.
(Reporting by Ben Hirschler; Editing by David Cowell)
- Tweet this
- Share this
- Digg this
- Hungary plans new tax on Internet traffic, public calls for rally
- Canada's parliament attacked near where PM Harper was speaking |
- ECB cools speculation over bank health checks ahead of results
- Bank of England minutes add to signs rate hike on back burner
- Tour de France organisers unveil sparkling 2015 route